Korea Steps Up Efforts To Contain MERS Outbreak
This article was originally published in PharmAsia News
The outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea is worsening, with the number of confirmed cases and fatalities continuing to climb. Struggling to contain the spread of the disease, the central government has announced it will step up efforts with provincial authorities, the private sector, the military and schools to ease the situation.
You may also be interested in...
South Korea authorities talk to foreign media about the country's experience and successes in dealing with the COVID-19 situation, lessons learned, preparations being made to return to everyday life and R&D activity.
Sanofi’s decision to return to originator Hanmi all rights to the novel diabetes candidate efpeglenatide, which is in global Phase III trials, has placed the South Korean pharma in a difficult spot. Unless there are some surprisingly positive data, finding a major global partner for commercialization may be tough.
South Korea authorities talk to foreign media about the country's experience and successes in dealing with the COVID-19 situation, progress in drug and vaccine development, lessons learned and the preparations being made to return to everyday life.